Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7196)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2022 (publication date) through Jun 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Prasoppokakorn T, Chan WK, Wong VWS, Pitisuttithum P, Mahadeva S, Nik Mustapha NR, Wong GLH, Leung HHW, Sripongpun P, Treeprasertsuk S. Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease . World J Gastroenterol 2022; 28(15): 1563-1573 [PMID: 35582126 DOI: 10.3748/wjg.v28.i15.1563] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i15/1563.htm |
| Number | Citing Articles |
| 1 |
Mohammadjavad Sotoudeheian, Reza Azarbad, Seyed-Mohamad-Sadegh Mirahmadi. Investigating the correlation between polyunsaturated fatty acids intake and non-invasive biomarkers of liver fibrosis. Clinical Nutrition ESPEN 2024; 63: 46 doi: 10.1016/j.clnesp.2024.06.016
|
| 2 |
Xiuru Gong, Yaxin Guo, Tingting Zhu, Dongwei Xing, Qi Shi, Minguang Zhang. Noninvasive assessment of significant liver fibrosis in rabbits by spectral CT parameters and texture analysis. Japanese Journal of Radiology 2023; 41(9): 983 doi: 10.1007/s11604-023-01423-0
|
| 3 |
Antonella Mosca, Andrea Pietrobattista, Giuseppe Maggiore. Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics?. Pediatric Reports 2024; 16(2): 288 doi: 10.3390/pediatric16020025
|
| 4 |
Chuan-Xi Wang, Jing-Jing Hou, Si-Yu Lin, Jiang-Hui Wang, Jing-Jing Ding, Chang Liu, Zheng-Xuan Jiang, Ning Bao. Association between liver fibrosis’s noninvasive scores and retinal imaging changes: insights from NHANES. Journal of Health, Population and Nutrition 2025; 44(1) doi: 10.1186/s41043-025-00805-6
|
| 5 |
Hao-ming He, Shu-wen Zheng, Yi-nong Chen, Long-yang Zhu, Zhe Wang, Si-qi Jiao, Fu-rong Yang, Yi-hong Sun. A Comparison of the Prognostic Value of Liver Fibrosis Scores in Acute Myocardial Infarction Patients With and Without Type 2 Diabetes. Angiology 2024; 75(3): 219 doi: 10.1177/00033197231197230
|
| 6 |
Mohammadjavad Sotoudeheian. Value of Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) in Assessing Liver Fibrosis in Metabolic Dysfunction-Associated Liver Disease: A Comprehensive Review of its Serum Biomarker Role. Current Protein & Peptide Science 2025; 26(1): 6 doi: 10.2174/0113892037315931240618085529
|
| 7 |
Hanzhu Chen, Wenya Ren, Xingdi Yang, Piao Hu, Shouhao Wang, Chengan Xu, Fei Lv, Yue Zhao, Qiaoqiao Yin, Wei Zheng, Jing Xu, Hongying Pan. Development and validation of a noninvasive prediction model for significant hepatic liver fibrosis in Chinese patients with autoimmune hepatitis. Annals of Hepatology 2024; 29(3): 101287 doi: 10.1016/j.aohep.2024.101287
|
| 8 |
Xian Yang, Jiaxin Wang, Xiaofang Zhang, Liangyan Wu, Ruxin Wang, Jianrong Lu, Lihong Wang. The liver fibrosis‐8 index is a predictor for all‐cause mortality in cardiovascular disease patients: A cohort study. Diabetes, Obesity and Metabolism 2024; 26(12): 5971 doi: 10.1111/dom.15971
|
| 9 |
C. Vikneshwaran Chandra Kumar, Ruben Skantha, Wah-Kheong Chan. Non-invasive assessment of metabolic dysfunction–associated fatty liver disease. Therapeutic Advances in Endocrinology and Metabolism 2022; 13 doi: 10.1177/20420188221139614
|